State Ledger
Company profile

Structure Therapeutics Inc. CIK 1888886

Ticker
GPCR (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
South San Francisco, CA 94080
Fiscal year end
2025 (FY)
Market Data
Close
$23.94
Change
-$1.57
Change %
-6.15%
Volume
61,103

GPCR · trading date Oct 12, 2026 · previous close $25.51 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$141.20M
Total assets
$1.58B
Total liabilities
$67.54M
Stockholders' equity
$1.52B
Cash & equivalents
$799.62M
Operating income
-$176.56M
Operating cash flow
-$222.20M
Capital expenditures
$3.61M

Fiscal year 2025, via 10-K filed 2026-02-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$225.81M
Free cash flow margin
—
Liabilities / assets
4.3%
Equity / assets
95.7%
CapEx / revenue
—
Operating cash flow / net income
1.57×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$141.20M $1.58B $67.54M $1.52B
2024 — -$122.53M $903.33M $38.49M $864.84M
2023 — -$89.62M $482.02M $29.05M $452.97M
2022 — -$51.32M $97.85M $13.01M -$115.14M
Company Details
SIC code
2834
State of incorporation
E9
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-08
Financials filed via
Form 10-K
filed 2026-02-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
South San Francisco, CA 94080
601 GATEWAY BLVD SUITE 900
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:20 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies